Supplementary Figure S1 from Combined MEK and BCL-2/XL Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient–Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure 1 shows the analysis of MEK/ERK pathway activation in HGSOC PDX models
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362609967